¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"focal lesion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • squamous intraepithelial lesion
    ÆíÆò»óÇdz»º´ÅÍ
  • stereotactic lesion making
    Á¤À§º´Å͹߻ý¼ú
  • subcortical lesion
    °ÑÁú¹Øº´ÅÍ, ÇÇÁúÇϺ´º¯
  • systemic lesion
    °èÅ뺴ÅÍ
  • septic lesion
    ÆÐÇ÷º´ÅÍ
  • skin lesion
    ÇǺκ´ÅÍ, ÇǺÎȯºÎ
  • soap-bubble lesion
    ºñ´©°Åǰº´ÅÍ
  • target lesion
    Ç¥Àûº´ÅÍ
  • ulcerative lesion
    ±Ë¾çº´ÅÍ
  • upper motor neuron lesion
    À§¿îµ¿½Å°æ¼¼Æ÷º´ÅÍ, »óÀ§¿îµ¿½Å°æ¿øº´º¯
  • verrucous lesion
    »ç¸¶±Í¸ð¾çº´ÅÍ
  • vesicular lesion
    Àܹ°Áýº´ÅÍ, ¼Ò¼öÆ÷º´ÅÍ
  • wire loop lesion
    ö»ç°í¸®º´ÅÍ
  • xanthomatous lesion
    Ȳ»öÁ¾º´ÅÍ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • solitary lesion
    °í¸³º´ÅÍ
  • space consuming lesion
    °ø°£¼Òºñº´ÅÍ
  • space occupying lesion
    °ø°£Á¡À¯º´ÅÍ
  • squamous intraepithelial lesion
    ÆíÆò»óÇdz»º´ÅÍ
  • subcortical lesion
    °ÑÁú¹Øº´ÅÍ
  • systemic lesion
    °èÅ뺴ÅÍ
  • target lesion
    Ç¥Àûº´ÅÍ
  • traumatic lesion
    ¿Ü»óº´ÅÍ
  • trophic lesion
    ¿µ¾ç¼ºº´ÅÍ
  • ulcerative lesion
    ±Ë¾çº´ÅÍ
  • upper motor neuron lesion
    À§¿îµ¿½Å°æ¼¼Æ÷º´ÅÍ
  • verrucous lesion
    »ç¸¶±Í¸ð¾çº´ÅÍ
  • vesicular lesion
    Àܹ°Áýº´ÅÍ, ¼Ò¼öÆ÷º´ÅÍ
  • wire loop lesion
    °í¸®¸ð¾çº´ÅÍ
  • xanthomatous lesion
    Ȳ»öÁ¾º´ÅÍ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • biochemical lesion
    »ýÈ­ÇÐÀû ¼Õ»ó(¡­áßß¿).
  • butterfly lesion
    ³ªºñ¾ç º´º¯
  • cauda equina lesion
    ¸¶¹Ì º´º¯(º´¼Ò)
  • coin lesion
    µ¿ÀüÇü º´º¯
  • coin lesion
    µ¿ÀüÇü º´º¯(¡­û¡ Ü»)ܨ
  • dermal melanocytic lesion
    ÁøÇǸá¶ó´Ñ¼¼Æ÷º´º¯
  • destructive lesion
    ÆÄ±«¼º º´º¯(¡­Ü»Ü¨).
  • echogenic lesion
    ¿¡ÄÚ ¹ß»ý º´¼Ò
  • epidermal melanocytic lesion
    Ç¥ÇÇ ¸á¶ó´Ñ¼¼Æ÷¼º º´º¯
  • gelatinous lesion
    Á¡¾×¼º, ±³Áú¼º Á©¶óƾ¾ç º´º¯
  • grottons lesion
    Grotton º´º¯
  • impaction lesion
    ¸Åº¹¼º º´º¯(¡­Ü»Ü¨).
  • internal lesion
    ³»ºÎ¼Õ»ó(¡­áßß¿).
  • intracranial expanding lesion
    µÎ°³³»ÆØÃ¢¼º º´º¯(¡­ø³óìàõܻܨ).
  • lesion
    º´º¯
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MGL minor glomerular lesion
MHL medial hypothalamic lesion
MLD manual lymph drainage; median lethal dose; metachromatic leukodystrophy; minimal lesion disease; min...
MLEL malignant lymphoepithelial lesion
MLGN minimal lesion glomerulonephritis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FNH Focal Nodular Hyperplasia
FSGS Focal Segmental Glomerulosclerosis
FA focal adhesion
FSGS Focal and segmental glomerulosclerosis
FCD Focal cortical dysplasia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • higher CNS neuraxis lesion
    »óºÎ ÁßÃ߽Űæ°è Ãà»ö º´¼Ò
  • initial lesion
    Ãʰ¨¿°¼Ò, Ãʱ⠺´º¯
    µ¿ÀǾî=
  • intrahepatic lesion
    °£ ³»ºÎ º´¼Ò
  • lentil-size lesion
    ·»ÁîÄá Å©±âÀÇ º´¼Ò
  • lesion
    º´º¯, º´¼Ò
    ºÎºÐÀû ±â´ÉÀÇ ¼Ò½ÇÀ̳ª Á¶Á÷ÀÇ º´¸®Àû ¿Ü»óÀû ºÒ¿¬¼Ó¼º.
  • local lesion
    ±¹¼Ò º´º¯
    ±¹¼ÒÀûÀÎ ºÎÀ§¿¡ ¹Þ°Ô µÇ´Â º´º¯, ¿Ü»ó, º´¼Ò, ¼Õ»ó, Àå¾Ö. ±¹¼ÒÀûÀ¸·Î ÀϾ°Ô µÇ´Â º´¸®Àû ¿Ü»ó¼ºÀÇ Á¶Á÷ Àå¾Ö, ¶Ç´Â ¾î¶² ºÎºÐÀÇ ±â´É »ó½Ç.
  • lymphoepithalial lesion
    ¸²ÇÁ»óÇǼº º´¼Ò
  • malignant lesion
    ¾Ç¼º º´¼Ò
  • mass lesion
    Á¾±«¼º º´º¯
  • mechanically disturbing lesion
    ±â°èÀûÀ¸·Î Àå¾Ö°¡ µÇ´Â º´¼Ò
  • metastatic neoplastic lesion
    ÀüÀ̼º ¾ÏÁ¾
    ¸Ö¸® ¶³¾îÁø ºÎÀ§ÀÇ ¿ø¹ß¼º Á¾¾ç¿¡¼­ ±¸°­³» ³ªÅ¸³­ ÀüÀÌ º´¼Ò.
  • nil : ¾Æ¹«°Íµµ ¾ø´Â, 0ÀÇ.

    nil lesion

    ¹Ì¼Ò º´º¯
  • nodular lesion
    °áÀý¼º º´¼Ò
  • ocular lesion
    ¾È±¸ º´¼Ò
  • overlapping lesion
    Áߺ¹ º´¼Ò
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
posterior focal point The point of a compound optical system where parallel rays entering the system are focused.
(05 Mar 2000)
cutaneous focal mucinosis Flesh-coloured papules of the skin, composed of homogenous mucinous material with scattered fibroblasts.
(05 Mar 2000)
proximal femoral focal deficiency A congenital defect in which variable portions of the upper end of the femur are reduced or absent.
(05 Mar 2000)
negative focal length <physics> The focal length of a negative lens. Parallel rays impinging on a negative lens can be traced to a virtual focus which exists on the same side of the lens as the impinging rays. The distance from the second principal point of the lens to this second focal point is measured on the same side of the lens as is the object.
See: negative lens, focal length.
(05 Aug 1998)
dystonia, focal, due to blepharospasm The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal.
(12 Dec 1998)
dystonia, focal, due to torticollis Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward.
(12 Dec 1998)
oral focal mucinosis An area of myxomatous connective tissue; the mucosal counterpart of cutaneous focal mucinosis.
(05 Mar 2000)
equivalent focal length <microscopy> The focal length of the simple lens that has the same power as the compound lens. The stated focal lengths of microscope objectives are the equivalent focal length since their front and back focal lengths are very different.
(05 Aug 1998)
focal Limited to one specific area.
(16 Dec 1997)
focal adhesion <cell biology> Areas of close apposition and thus presumably anchorage points, of the plasma membrane of a fibroblast (for example) to the substratum over which it is moving.
Usually 1m x 0.2 m with the long axis parallel to the direction of movement, always associated with a cytoplasmic microfilament bundle that is attached via several proteins to the plasma membrane at an area of high protein concentration (this is noticeably electron dense in electron micrographs). Focal adhesions tend to be characteristic of slow moving cells.
(18 Nov 1997)
focal amyloidosis A localised form of amyloidosis in which amyloid occurs as masses or nodules beneath the skin or mucous membranes, e.g., in the larynx.
Synonym: amyloid tumour, focal amyloidosis.
(05 Mar 2000)
focal and segmental hyalinosis <nephrology> A kidney disorder that results in fibrosis and scarring in the kidney glomerulus. The cause is unknown but some cases can result from reflux nephropathy. The clinical manifestation of this kidney disorder is nephrotic syndrome.
Symptoms include weight gain, swelling, hypertension and foamy urine. High blood cholesterol and triglyceride levels are also seen with this disorder. Treatment has included the use of corticosteroids and immunosuppressives. Antihypertensive agents and diuretics may also be necessary. Over one-half will develop chronic renal failure within 10 years of diagnosis.
(27 Sep 1997)
focal appendicitis Acute appendicitis involving only part of the appendix, sometimes at the site of, or distal to, an obstruction of the lumen.
(05 Mar 2000)
focal condensing osteitis A reaction of bone to a mild bacterial infection, often the result of a carious tooth, in persons with a high degree of tissue resistance; results in a localised radio-opacity.
Synonym: focal condensing osteitis.
(05 Mar 2000)
focal depth Depth of focus, the greatest distance through which an object point can be moved while maintaining a clear image.
Synonym: penetration.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á